Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Immunoinhibition of ristocetin-induced platelet aggregation.
R L Nachman, … , E A Jaffe, B B Weksler
R L Nachman, … , E A Jaffe, B B Weksler
Published January 1, 1977
Citation Information: J Clin Invest. 1977;59(1):143-148. https://doi.org/10.1172/JCI108612.
View: Text | PDF
Research Article

Immunoinhibition of ristocetin-induced platelet aggregation.

  • Text
  • PDF
Abstract

Human platelets washed and fixed in paraformaldehyde aggregate in the presence of the antibiotic ristocetin and normal plasma. This aggregation response is abolished after digestion of the fixed platelets with chymotrypsin. Antisera to fixed washed platelets were produced in rabbits and absorbed with chymotrypsin-treated, fixed washed platelets. Monovalent Fab fragments obtained from the isolated gamma-globulin fractions of the antisera blocked ristocetin-induced aggregation of fixed washed platelets in buffer and normal platelets in platelet-rich plasma. By double-antibody immunoprecipitation, it was shown that the antibody which blocked the ristocetin reaction interacted with a platelet membrane surface protein of mol wt 155,000. The results suggest that the glycoprotein I complex on the surface of the human platelet mediates ristocetin-induced von Willebrand factor-dependent platelet aggregation.

Authors

R L Nachman, E A Jaffe, B B Weksler

×

Total citations by year

Year: 2017 2013 2008 1998 1993 1991 1990 1989 1988 1986 1985 1984 1983 1982 1981 1980 1979 1978 1977 Total
Citations: 1 1 1 1 1 2 1 1 1 1 4 2 7 4 6 3 9 3 1 50
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (50)

Title and authors Publication Year
Men and Women Differ in the Biochemical Composition of Platelet-Rich Plasma
G Xiong, N Lingampalli, JC Koltsov, LL Leung, N Bhutani, WH Robinson, CR Chu
The American journal of sports medicine 2017
Microfluidics and Coagulation Biology
TV Colace, GW Tormoen, OJ McCarty, SL Diamond
Annual Review of Biomedical Engineering 2013
Decreased clearance of von Willebrand factor in a patient with type 2B von Willebrand disease following development of immune thrombocytopenia
ZJ Wang, N Onwuzurike, MU Callaghan, M Rajpurkar, M Chitlur, JM Lusher
Pediatric Blood & Cancer 2008
Type 2M von Willebrand Disease: F606I and I662F Mutations in the Glycoprotein Ib Binding Domain Selectively Impair Ristocetin- but not Botrocetin-Mediated Binding of von Willebrand Factor to Platelets
CA Hillery, DJ Mancuso, JE Sadler, JW Ponder, MA Jozwiak, PA Christopherson, JC Gill, JP Scott, RR Montgomery
Blood 1998
The assembly of the prothrombinase complex on adherent platelets
NA Swords, KG Mann
Arteriosclerosis Thrombosis and Vascular Biology 1993
1 An approach to the management of infants with impaired haemostasis
M Andrew
Baillière's Clinical Haematology 1991
von Willebrand factor
JE Sadler
The Journal of biological chemistry 1991
The Clinical Significance of Platelet Membrane Glycoproteins
RP McEver
Hematology/Oncology Clinics of North America 1990
The Effect of Diclofenac Sodium on Renal Function
AC Kinn, J Elbarouni, P Seideman, A Sollevi
Scandinavian Journal of Urology and Nephrology 1989
Isolation and characterization of human platelet glycoprotein IX
GJ Roth, J Ozols, DJ Nugent, SA Williams
Biochemical and Biophysical Research Communications 1988
Identification of the thrombin receptor on human platelets by chemical crosslinking
J Takamatsu, MK 3rd, HR Gralnick
Journal of Clinical Investigation 1986
Structure and function of platelet membrane glycoproteins Ib and V. Effects of leukocyte elastase and other proteases on platelets response to von Willebrand factor and thrombin
AN WICKI, KJ CLEMETSON
European Journal of Biochemistry 1985
Cloning and characterization of two cDNAs coding for human von Willebrand factor
JE Sadler, BB Shelton-Inloes, JM Sorace, JM Harlan, K Titani, EW Davie
Proceedings of the National Academy of Sciences 1985
Advances in Hemostasis and Thrombosis
A Cajozzo, R Perricone, PD Marco, P Palazzolo
1985
Platelet Membrane Glycoproteins
JN George, AT Nurden, DR Phillips
1985
Preparation of monoclonal antibodies against glycoprotein IIIa of human platelets. Their effect on platelet aggregation
JA MELERO, J GONZALEZ-RODRIGUEZ
European Journal of Biochemistry 1984
Neonatal Thrombocytopenia
M Andrew, J Kelton
Clinics in Perinatology 1984
Monoclonal Antibodies against Platelet Membrane Glycoproteins. Characterization and Effect on Platelet Function
JL McGREGOR, J BROCHIER, F WILD, G FOLLEA, MC TRZECIAK, E JAMES, M DECHAVANNE, L McGREGOR, KJ CLEMETSON
European Journal of Biochemistry 1983
Heparin-binding platelet proteins demonstrated by crossed affinity immunoelectrophoresis
GO Gogstad, NO Solum, MB Krutnes
British Journal of Haematology 1983
Antibodies against platelet membrane glycoproteins
CS Jenkins, KJ Clemetson, EF Ali-Briggs
British Journal of Haematology 1983
Potentiation of wheat germ agglutinin aggregation of platelets by von Willebrand protein and by a 116,000 molecular weight tryptic fragment
SE Martin, CW Francis, VJ Marder
Thrombosis Research 1983
Antibodies against platelet membrane glycoproteins.: III. EFFECT ON THROMBIN- AND BOVINE VON WILLEBRAND FACTOR-INDUCED AGGREGATION
CS Jenkins, KJ Clemetson, EF Ali-Briggs
British Journal of Haematology 1983
Antiplatelet Agents: Rationale and Results
JG Kelton
Clinics in Haematology 1983
Purification of human platelet calcium-activated protease. Effect on platelet and endothelial function
N Yoshida, B Weksler, R Nachman
The Journal of biological chemistry 1983
Complex formation of platelet membrane glycoproteins IIb and IIIa with fibrinogen
RL Nachman, LL Leung
Journal of Clinical Investigation 1982
Thrombin-induced exposure and prostacyclin inhibition of the receptor for factor VIII/von Willebrand factor on human platelets
T Fujimoto, S Ohara, J Hawiger
Journal of Clinical Investigation 1982
Association of membrane and cytoplasmic proteins with the cytoskeleton in blood platelets
A Rotman, J Heldman, S Linder
Biochemistry 1982
The interaction of human coagulation factor Va with platelets
WH Kane, PW Majerus
The Journal of biological chemistry 1982
Platelet Fc receptor. Increased expression in myeloproliferative disease
A Moore, RL Nachman
Journal of Clinical Investigation 1981
Properties of human asialo-factor VIII. A ristocetin-independent platelet-aggregating agent
LD Marco, SS Shapiro
Journal of Clinical Investigation 1981
Antibodies against Platelet Membrane Glycoproteins
EF Ali-Briggs, KJ Clemetson, CS Jenkins
British Journal of Haematology 1981
Racial Differences in Ristocetin-induced Platelet Aggregation
GR Buchanan, CA Holtkamp, EN Levy
British Journal of Haematology 1981
Thrombin-induced platelet membrane glycoprotein IIb and IIIa complex formation. An electron microscope study
MJ Polley, LL Leung, FY Clark, RL Nachman
Journal of Experimental Medicine 1981
Isolation, purification, and partial characterization of platelet membrane glycoproteins IIb and IIIa
LL Leung, T Kinoshita, RL Nachman
The Journal of biological chemistry 1981
Platelet activation and wheat germ agglutinin-binding
A Rotman, J Heldman
FEBS Letters 1980
Parallel inhibition of ristocetin and polycation-induced platelet agglutination
TK Rosborough
Thrombosis Research 1980
Serotonin binding sites of human blood platelets
BK Kim, M Steiner, MG Baldini
Analytical Biochemistry 1980
Demonstration and characterization of specific binding sites for factor VIII/von Willebrand factor on human platelets
KJ Kao, SV Pizzo, PA McKee
Journal of Clinical Investigation 1979
Studies on the Mechanism of Ristocetin-induced Platelet Aggregation: Binding of Factor VIII to Platelets
MD Schneider-Trip, CS Jenkins, LH Kahlé, A Sturk, JW Cate
British Journal of Haematology 1979
Further Studies on a Specific Platelet Antibody Found in Bernard-Soulier Syndrome and its Effects on Normal Platelet Function
G Tobelem, S Levy-Toledano, AT Nurden, L Degos, JP Caen, C Malmsten, H Kindahl
British Journal of Haematology 1979
Thrombin Receptors of Human Platelets: Thrombin Binding and Antithrombin Properties of Glycoprotein I
P Ganguly, NL Gould
British Journal of Haematology 1979
Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation
KJ Kao, SV Pizzo, PA McKee
Proceedings of the National Academy of Sciences 1979
Human megakaryocytes. I. Characterization of the membrane and cytoplasmic components of isolated marrow megakaryocytes
EM Rabellino, RL Nachman, N Williams, RJ Winchester, GD Ross
Journal of Experimental Medicine 1979
Human platelet membrane receptor for bovine von Willebrand factor (platelet aggregating factor): an integral membrane glycoprotein
HA Cooper, KJ Clemetson, EF Lüscher
Proceedings of the National Academy of Sciences 1979
Structural analysis of human platelet membrane glycoprotein I complex
RL Nachman, T Kinoshita, B Ferris
Proceedings of the National Academy of Sciences 1979
Interaction of wheat germ agglutinin with rat platelets: Observations on stimulus-response coupling
P Ganguly, NG Fossett
Thrombosis Research 1979
Interaction of Platelet Membrane Receptors with von Willebrand Factor, Ristocetin, and the Fc Region of Immunoglobulin G
A Moore, GD Ross, RL Nachman
Journal of Clinical Investigation 1978
MEMBRANE GLYCOPROTEINS AND HUMAN PLATELET FUNCTION
AT Nurden, JP Caen
British Journal of Haematology 1978
Wheat germ agglutinin affinity chromatography of human platelet membrane glycoproteins
RL Nachman, E Tarasov, BB Weksler, B Ferris
Thrombosis Research 1978
Procoagulant Specificity of Factor VIII Inhibitor
HC Yang, M Kuzur
British Journal of Haematology 1977

← Previous 1 2 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts